EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting PCSK9 in Vascular Smooth Muscle Cells: An Effective Strategy to Suppress Ferroptosis and Attenuate Abdominal Aortic Aneurysm Progression

Mengdie Xia, Man Li, Yanyu Chen, Jialin Chen, Yuting Cui, Xi-Long Zheng, Jing Yang, Bingzhao Li, Xiaofeng Ma, Miao Liu iD, Gang Fan, Juan Peng und 2 weitere

Cell Proliferation · 2026-11 · 59 (11)

DOI: 10.1111/cpr.70244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 10.06.2026. Verfasst von Mengdie Xia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: Ferroptosis, Aortic Aneurysm, Abdominal, Muscle, Smooth, Vascular, Proprotein Convertase 9. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Hunan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abdominal aortic aneurysm (AAA) lacks effective pharmacotherapy. This study examines whether proprotein convertase subtilisin/kexin type 9 (PCSK9) drives ferroptosis in vascular smooth muscle cells (VSMCs) and whether its pharmacological degradation mitigates disease progression. PCSK9 is enriched in VSMCs of human AAA and in murine models induced by PPE or Ang II. SMC‐specific PCSK9 overexpression ( PCSK9 SMC OE ) increases aortic diameter, aggravates elastin fragmentation and collagen deposition and elevates MMP2/9 expression. Within aortic lesions, PCSK9 SMC OE enhances iron accumulation and lipid peroxidation while reducing glutathione GPX4, consistent with ferroptosis. In primary VSMCs, PCSK9 overexpression suppresses GPX4 and glutathione, increases malondialdehyde and Fe 2+ levels and impairs viability, whereas PCSK9 knockdown attenuates Ang II–induced ferroptosis. Mechanistically, PCSK9 triggers ferritinophagy, as shown by decreased ferritin heavy chain‐1 (FTH1) and nuclear receptor coactivator‐4 (NCOA4), an increased LC3‐II/I ratio and enhanced FTH1–LAMP1 colocalisation. Autophagy inhibition with bafilomycin A1 blocks Fe 2+ accumulation and rescues ferroptotic indices. The cell‐permeable peptide Cadd4 promotes PCSK9 degradation, restores FTH1 and NCOA4 and suppresses ferroptosis in VSMCs. In PPE and Ang II models, Cadd4 reduces aortic dilation, preserves medial structure and normalises ferroptosis and ferritinophagy markers. PCSK9 drives ferritinophagy‐dependent ferroptosis in VSMCs, and Cadd4 represents a promising therapeutic strategy for AAA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisAortic Aneurysm, AbdominalMuscle, Smooth, VascularProprotein Convertase 9Myocytes, Smooth MusclePCSK9 InhibitorsAnimalsHumansMiceMaleDisease ProgressionMice, Inbred C57BLAutophagy

Stichwörter der Autor:innen

PCSK9PROTACabdominal aortic aneurysmferroptosisvascular smooth muscle cells

Substanzen

Proprotein Convertase 9PCSK9 protein, humanPCSK9 Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China.
  • Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, School of Basic Medical Science…
  • Department of Cardiovascular Medicine, the Second Affiliated Hospital, University of South China, Hunan, China.
  • Departments of Biochemistry & Molecular Biology and Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Metabolism and Endocrinology, Shenzhen University Sixth Affiliated Hospital, Shenzhen Nanshan People's Hospital, Guangdong, China.
  • Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Miao Liu

Förderung

  • Science and Technology Program of Hunan Province
  • National Natural Science Foundation of China

Zitieren

APA

Xia, M., Li, M., Chen, Y., Chen, J., Cui, Y., Zheng, X. L., Yang, J., Li, B., Ma, X., Liu, M., Fan, G., Peng, J., Dai, X., & Tang, Z. (2026). Targeting PCSK9 in Vascular Smooth Muscle Cells: An Effective Strategy to Suppress Ferroptosis and Attenuate Abdominal Aortic Aneurysm Progression. Cell Proliferation, 59(11). https://doi.org/10.1111/cpr.70244

Vancouver

Xia M, Li M, Chen Y, Chen J, Cui Y, Zheng XL, et al. Targeting PCSK9 in Vascular Smooth Muscle Cells: An Effective Strategy to Suppress Ferroptosis and Attenuate Abdominal Aortic Aneurysm Progression. Cell Proliferation. 2026;59(11). doi:10.1111/cpr.70244

BibTeX
@article{Xia2026,
  author = {Xia, Mengdie and Li, Man and Chen, Yanyu and Chen, Jialin and Cui, Yuting and Zheng, Xi-Long and Yang, Jing and Li, Bingzhao and Ma, Xiaofeng and Liu, Miao and Fan, Gang and Peng, Juan and Dai, Xiaoyan and Tang, Zhihan},
  title = {Targeting PCSK9 in Vascular Smooth Muscle Cells: An Effective Strategy to Suppress Ferroptosis and Attenuate Abdominal Aortic Aneurysm Progression},
  journal = {Cell Proliferation},
  year = {2026},
  volume = {59},
  number = {11},
  doi = {10.1111/cpr.70244}
}
Kostenlos starten →